We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics
ALDX

120 hedge funds and large institutions have $252M invested in Aldeyra Therapeutics in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 41 increasing their positions, 37 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 37

7% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 14

1% more funds holding

Funds holding: 119 → 120 (+1)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

2.18% less ownership

Funds ownership: 66.64% → 64.46% (-2.2%)

23% less capital invested

Capital invested by funds: $328M → $252M (-$75.2M)

38% less call options, than puts

Call options by funds: $1.34M | Put options by funds: $2.16M

Holders
120
Holders Change
+1
Holders Change %
+0.84%
% of All Funds
1.9%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
41
Reduced
37
Closed
14
Calls
$1.34M
Puts
$2.16M
Net Calls
-$820K
Net Calls Change
+$2.53M

Top Buyers

1
BlackRock
BlackRock
New York
+$1.04M
2
Two Sigma Investments
Two Sigma Investments
New York
+$1.01M
3
Citadel Advisors
Citadel Advisors
Florida
+$999K
4
LCM
Laurion Capital Management
New York
+$946K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$740K

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.02M
2
Invesco
Invesco
Georgia
-$3.47M
3
Marshall Wace
Marshall Wace
United Kingdom
-$1.54M
4
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$1.42M
5
AllianceBernstein
AllianceBernstein
Tennessee
-$1.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
76
American International Group
New York
$155K +$6.13K +826 +4%
Federated Hermes
77
Federated Hermes
Pennsylvania
$141K – – –
AQR Capital Management
78
AQR Capital Management
Connecticut
$140K -$38.9K -5,245 -20%
Wolverine Trading
79
Wolverine Trading
Illinois
$135K +$21.6K +2,908 +17%
HP
80
Hikari Power
Japan
$134K – – –
VOYA Investment Management
81
VOYA Investment Management
Georgia
$129K +$5.36K +723 +4%
Manulife (Manufacturers Life Insurance)
82
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$127K – – –
New York State Common Retirement Fund
83
New York State Common Retirement Fund
New York
$125K +$3.59K +484 +3%
Allspring Global Investments
84
Allspring Global Investments
North Carolina
$124K +$138K +18,618 New
CIBC Private Wealth Group
85
CIBC Private Wealth Group
Georgia
$115K +$127K +17,150 New
Vontobel Holding
86
Vontobel Holding
Switzerland
$104K -$161K -21,642 -58%
GCP
87
GSA Capital Partners
United Kingdom
$102K -$478K -64,443 -81%
CAN
88
Cetera Advisor Networks
California
$101K -$13.9K -1,873 -11%
SM
89
Sciencast Management
New Jersey
$101K +$112K +15,125 New
CSS
90
Cubist Systematic Strategies
Connecticut
$99.8K +$111K +14,933 New
PFCS
91
Pale Fire Capital SE
Czech Republic
$98.2K +$109K +14,700 New
EFM
92
E Fund Management
China
$93K +$2.43K +327 +2%
State Board of Administration of Florida Retirement System
93
State Board of Administration of Florida Retirement System
Florida
$90K +$1.93K +260 +2%
ASRS
94
Arizona State Retirement System
Arizona
$89.1K +$1.34K +180 +1%
Teacher Retirement System of Texas
95
Teacher Retirement System of Texas
Texas
$89K +$4.46K +601 +5%
Zurich Cantonal Bank
96
Zurich Cantonal Bank
Switzerland
$82K – – –
AIM
97
Aigen Investment Management
New York
$80K +$88.9K +11,980 New
TI
98
Trexquant Investment
Connecticut
$77.7K -$29.2K -3,940 -25%
UBS AM
99
UBS AM
Illinois
$74.9K +$83.2K +11,212 New
American Century Companies
100
American Century Companies
Missouri
$74.7K -$69.2K -9,329 -45%
2 3
4
5 6

ALDX Hedge Fund Activity: Q3 2023 in Review

120 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q3 2023, worth a combined $252M — down 23% from $328M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ALDX positions and 14 closed out — a net gain of 1 holder — while 41 added to existing stakes and 37 trimmed.

The largest buyer was BlackRock, adding an estimated $1.04M. The largest seller was Fidelity Investments, cutting an estimated $5.02M.

  • 120 institutional investors held Aldeyra Therapeutics (ALDX) as of Q3 2023, up from 119 in Q2 2023.
  • Funds reported $252M of Aldeyra Therapeutics stock for Q3 2023, down 23% quarter-over-quarter.
  • 15 funds opened new Aldeyra Therapeutics positions in Q3 2023 and 14 closed out, a net change of +1 holder.
  • The largest Aldeyra Therapeutics buyer in Q3 2023 was BlackRock, an estimated $1.04M added.
  • The largest Aldeyra Therapeutics seller in Q3 2023 was Fidelity Investments, an estimated $5.02M sold.

Based on aggregated 13F filings for Q3 2023.